A detailed history of Hobbs Group Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Hobbs Group Advisors, LLC holds 281 shares of BMY stock, worth $16,179. This represents 0.01% of its overall portfolio holdings.

Number of Shares
281
Previous 282 0.35%
Holding current value
$16,179
Previous $11.7 Million 24.33%
% of portfolio
0.01%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 18, 2024

SELL
$39.66 - $51.75 $39 - $51
-1 Reduced 0.35%
281 $14.5 Million
Q2 2024

Jul 22, 2024

SELL
$40.25 - $52.99 $41,296 - $54,367
-1,026 Reduced 78.44%
282 $11.7 Million
Q4 2023

Feb 16, 2024

BUY
$48.48 - $57.85 $63,411 - $75,667
1,308 New
1,308 $67.1 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Hobbs Group Advisors, LLC Portfolio

Follow Hobbs Group Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hobbs Group Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hobbs Group Advisors, LLC with notifications on news.